Citigroup
QNTM

Citigroup’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Citigroup’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4 Buy
+1
New +$5 ﹤0.01% 5631

Other funds holding QNTM

PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Citigroup's QNTM Position: Q2 2026 in Review

Citigroup opened a new position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q2 2026: 1 share worth $4. The stake represents ﹤0.01% of the portfolio and ranks #5631 among its holdings.

8 funds tracked by Wall St. Rank hold QNTM as of Q2 2026.

  • Citigroup held 1 share of Quantum Biopharma Class B Subordinate Voting Shares worth $4 as of Q2 2026.
  • Quantum Biopharma Class B Subordinate Voting Shares was a new Citigroup position in Q2 2026.
  • Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5631 holding.
  • 8 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.